Antidiabetic effects of carassius auratus complex formula in high fat diet combined streptozotocin-induced diabetic mice

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Wang, Zhi Hong ^a   Hsu, Cheng Chin ^b,c   Lin, Hui Hsuan ^b,c   Chen, Jing Hsien ^b,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALDEHYDE REDUCTASE; ANTIDIABETIC AGENT; CARASSIUS AURATUS COMPLEX FORMULA; CHINESE DRUG; DIACYLGLYCEROL ACYLTRANSFERASE 1; DIACYLGLYCEROL ACYLTRANSFERASE 2; FRUCTOSAMINE; GLUCOSE; INSULIN; RESISTIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; CHINESE MEDICINE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; FRUCTOSAMINE BLOOD LEVEL; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GOLDFISH; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY HOMOGENATE; LIPID DIET; LIVER; LOW DRUG DOSE; LYCIUM CHINENSE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REHMANNIA GLUTINOSA; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRIACYLGLYCEROL BLOOD LEVEL; YAM;

EID: 84893202322     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/628473     Document Type: Article

References (47)

1. Gouda H. N., Sagoo G. S., Harding A.-H., Yates J., Sandhu M. S., Higgins J. P. T., The association between the peroxisome proliferator-activated receptor- γ 2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. American Journal of Epidemiology 2010 171 6 645 655 2-s2.0-77949397703 10.1093/aje/kwp450
2. Attele A. S., Zhou Y.-P., Xie J.-T., Wu J. A., Zhang L., Dey L., Pugh W., Rue P. A., Polonsky K. S., Yuan C.-S., Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002 51 6 1851 1858 2-s2.0-0036266324 (Pubitemid 34564298)
3. Hug C., Lodish H. F., The role of the adipocyte hormone adiponectin in cardiovascular disease. Current Opinion in Pharmacology 2005 5 2 129 134 2-s2.0-15044356709 10.1016/j.coph.2005.01.001 (Pubitemid 40378742)
4. Scherer P. E., Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006 55 6 1537 1545 2-s2.0-33747356154 10.2337/db06-0263 (Pubitemid 44324105)
5. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K., Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Journal of Clinical Investigation 2006 116 7 1784 1792 2-s2.0-33745834319 10.1172/JCI29126 (Pubitemid 44033298)
6. Steppan C. M., Bailey S. T., Bhat S., Brown E. J., Banerjee R. R., Wright C. M., Patel H. R., Ahima R. S., Lazar M. A., The hormone resistin links obesity to diabetes. Nature 2001 409 6818 307 312 2-s2.0-0035905758 10.1038/35053000 (Pubitemid 32151228)
7. Pang S. S., Le Y. Y., Role of resistin in inflammation and inflammation-related diseases. Cellular & Molecular Immunology 2006 3 1 29 34 2-s2.0-33745171469
8. Kamenov Z. A., Parapunova R. A., Georgieva R. T., Earlier development of diabetic neuropathy in men than in women with type 2 diabetes mellitus. Gender Medicine 2010 7 6 600 615 2-s2.0-78650911015 10.1016/j.genm.2010.11.001
9. Rossing P., Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history. Current Diabetes Reports 2006 6 6 479 483 2-s2.0-33845388491 10.1007/s11892-006-0083-y (Pubitemid 44896409)
10. Romero-Aroca P., Fernández-Balart J., Baget-Bernaldiz M., Martinez-Salcedo I., Méndez-Marín I., Salvat-Serra M., Buil-Calvo J. A., Changes in the diabetic retinopathy epidemiology after 14 years in a population of Type 1 and 2 diabetic patients after the new diabetes mellitus diagnosis criteria and a more strict control of the patients. Journal of Diabetes and Its Complications 2009 23 4 229 238 2-s2.0-67049087838 10.1016/j.jdiacomp.2008.02.012
11. Grimshaw C. E., Bohren K. M., Lai C.-J., Gabbay K. H., Human aldose reductase: pK of tyrosine 48 reveals the preferred ionization state for catalysis and inhibition. Biochemistry 1995 34 44 14374 14384 2-s2.0-0028810466 10.1021/bi00044a014
12. Raptis A. E., Viberti G., Pathogenesis of diabetic nephropathy. Experimental and Clinical Endocrinology and Diabetes 2001 109 supplement 2 S424 S437 2-s2.0-0034977765 10.1055/s-2001-18600 (Pubitemid 32577594)
13. Oyama T., Miyasita Y., Watanabe H., Shirai K., The role of polyol pathway in high glucose-induced endothelial cell damages. Diabetes Research and Clinical Practice 2006 73 3 227 234 2-s2.0-33746561172 10.1016/j.diabres.2006. 02.010 (Pubitemid 44131488)
14. Chung S. S. M., Chung S. K., Aldose reductase in diabetic microvascular complications. Current Drug Targets 2005 6 4 475 486 2-s2.0-21544463410 10.2174/1389450054021891 (Pubitemid 40921713)
15. Yamauchi T., Kamon J., Waki H., Murakami K., Motojima K., Komeda K., Ide T., Kubota N., Terauchi Y., Tobe K., Miki H., Tsuchida A., Akanuma Y., Nagai R., Kimura S., Kadowaki T., The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. The Journal of Biological Chemistry 2001 276 44 41245 41254 2-s2.0-0035798713 10.1074/jbc.M103241200
16. Grover J. K., Yadav S., Vats V., Medicinal plants of India with anti-diabetic potential. Journal of Ethnopharmacology 2002 81 1 81 100 2-s2.0-0036000246 10.1016/S0378-8741(02)00059-4 (Pubitemid 34518472)
17. Marles R. J., Farnsworth N. R., Antidiabetic plants and their active constituents. Phytomedicine 1995 2 2 137 189 2-s2.0-0028835878
18. Shu X.-S., Lv J.-H., Tao J., Li G.-M., Li H.-D., Ma N., Antihyperglycemic effects of total flavonoids from Polygonatum odoratum in STZ and alloxan-induced diabetic rats. Journal of Ethnopharmacology 2009 124 3 539 543 2-s2.0-67650688115 10.1016/j.jep.2009.05.006
19. Liu W. W., Ogata T., Sato S., Unoura K., Onodera J.-I., Superoxide scavenging activities of sixty Chinese medicines determined by an ESR spin-trapping method using electrogenerated superoxide. Yakugaku Zasshi 2001 121 4 265 270 2-s2.0-0035072829 10.1248/yakushi.121.265 (Pubitemid 32294496)
20. Jung H. A., Jung Y. J., Yoon N. Y., Jeong D. M., Bae H. J., Kim D.-W., Na D. H., Choi J. S., Inhibitory effects of Nelumbo nucifera leaves on rat lens aldose reductase, advanced glycation endproducts formation, and oxidative stress. Food and Chemical Toxicology 2008 46 12 3818 3826 2-s2.0-56149111156 10.1016/j.fct.2008.10.004
21. Gao X., Li B., Jiang H., Liu F., Xu D., Liu Z., Dioscorea opposita reverses dexamethasone induced insulin resistance. Fitoterapia 2007 78 1 12 15 2-s2.0-33845398363 10.1016/j.fitote.2006.09.015 (Pubitemid 44909357)
22. Lin C. L., Wang C. C., Chang S. C., Inbaraj B. S., Chen B. H., Antioxidative activity of polysaccharide fractions isolated from Lycium barbarum Linnaeus. International Journal of Biological Macromolecules 2009 45 2 146 151 2-s2.0-67349263881 10.1016/j.ijbiomac.2009.04.014
23. Huang W.-J., Niu H.-S., Lin M.-H., Cheng J.-T., Hsu F.-L., Antihyperglycemic effect of catalpol in streptozotocin-induced diabetic rats. Journal of Natural Products 2010 73 6 1170 1172 2-s2.0-77954080753 10.1021/np9008317
24. Srinivasan K., Viswanad B., Asrat L., Kaul C. L., Ramarao P., Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacological Research 2005 52 4 313 320 2-s2.0-23844504364 10.1016/j.phrs.2005.05.004 (Pubitemid 41175991)
25. Wang Y., Campbell T., Perry B., Beaurepaire C., Qin L., Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats. Metabolism 2011 60 2 298 305 2-s2.0-78751647742 10.1016/j.metabol.2010.02.005
26. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry 1951 193 1 265 275 2-s2.0-71849104860
27. Folch J., Lees M., Sloane S. G. H., A simple method for the isolation and purification of total lipides from animal tissues. The Journal of Biological Chemistry 1957 226 1 497 509 2-s2.0-70449158340
28. Kim Y. S., Kim N. H., Jung D. H., Jang D. S., Lee Y. M., Kim J. M., Kim J. S., Genistein inhibits aldose reductase activity and high glucose-induced TGF- β 2 expression in human lens epithelial cells. European Journal of Pharmacology 2008 594 1-3 18 25 2-s2.0-50549095066 10.1016/j.ejphar.2008.07.033
29. Nishinaka T., Yabe-Nishimura C., EGF receptor-ERK pathway is the major signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress. Free Radical Biology and Medicine 2001 31 2 205 216 2-s2.0-0035879832 10.1016/S0891-5849(01)00571-8 (Pubitemid 32607587)
30. Baker J. R., Metcalf P. A., Johnson R. N., Use of protein-based standards in automated colorimetric determinations of fructosamine in serum. Clinical Chemistry 1985 31 9 1550 1554 2-s2.0-0022219133 (Pubitemid 16011848)
31. Petrie J. R., Pearson E. R., Sutherland C., Implications of genome wide association studies for the understanding of type 2 diabetes pathophysiology. Biochemical Pharmacology 2011 81 4 471 477 2-s2.0-78751575640 10.1016/j.bcp.2010.11.010
32. Lowell B. B., Shulman G. I., Mitochondrial dysfunction and type 2 diabetes. Science 2005 307 5708 384 387 2-s2.0-12344305124 10.1126/science. 1104343 (Pubitemid 40139974)
33. Shi Y., Cheng D., Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolism. The American Journal of Physiology-Endocrinology and Metabolism 2009 297 1 E10 E18 2-s2.0-67650096808 10.1152/ajpendo.90949.2008
34. Nkondjock A., Receveur O., Fish-seafood consumption, obesity, and risk of type 2 diabetes: an ecological study. Diabetes and Metabolism 2003 29 6 635 642 2-s2.0-0345862121 (Pubitemid 38082167)
35. Fedor D., Kelley D. S., Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Current Opinion in Clinical Nutrition and Metabolic Care 2009 12 2 138 146 2-s2.0-61949365497 10.1097/MCO.0b013e3283218299
36. Nanri A., Mizoue T., Noda M., Takahashi Y., Matsushita Y., Poudel-Tandukar K., Kato M., Oba S., Inoue M., Tsugane S., Fish intake and type 2 diabetes in Japanese men and women: the Japan Public Health Center-based prospective study. The American Journal of Clinical Nutrition 2011 94 3 884 891 2-s2.0-80051989605 10.3945/ajcn.111.012252
37. McTernan P. G., McTernan C. L., Chetty R., Jenner K., Fisher F. M., Lauer M. N., Crocker J., Barnett A. H., Kumar S., Increased resistin gene and protein expression in human abdominal adipose tissue. Journal of Clinical Endocrinology and Metabolism 2002 87 5 2407 2410 2-s2.0-0036090282 10.1210/jc.87.5.2407 (Pubitemid 34521539)
38. Slawik M., Vidal-Puig A. J., Lipotoxicity, overnutrition and energy metabolism in aging. Ageing Research Reviews 2006 5 2 144 164 2-s2.0-33646806826 10.1016/j.arr.2006.03.004 (Pubitemid 43766261)
39. Kershaw E. E., Flier J. S., Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism 2004 89 6 2548 2556 2-s2.0-2942650969 10.1210/jc.2004-0395 (Pubitemid 38766330)
40. Bastard J.-P., Maachi M., Lagathu C., Kim M. J., Caron M., Vidal H., Capeau J., Feve B., Recent advances in the relationship between obesity, inflammation, and insulin resistance. European Cytokine Network 2006 17 1 4 12 2-s2.0-33745896155
41. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., Mori Y., Ide T., Murakami K., Tsuboyama-Kasaoka N., Ezaki O., Akanuma Y., Gavrilova O., Vinson C., Reitman M. L., Kagechika H., Shudo K., Yoda M., Nakano Y., Tobe K., Nagai R., Kimura S., Tomita M., Froguel P., Kadowaki T., The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine 2001 7 8 941 946 2-s2.0-17944365228 10.1038/90984 (Pubitemid 32756432)
42. U.S. Department of Health and Human Services, Diabetes: A National Plan for Action 2004 U.S. Department of Health and Human Services pp. 19-22
43. Gonzalez R. G., Barnett P., Aguayo J., Direct measurement of polyol pathway activity in the ocular lens. Diabetes 1984 33 2 196 199 2-s2.0-0021363571 (Pubitemid 14184708)
44. Ramana K. V., Chandra D., Srivastava S., Bhatnagar A., Srivastava S. K., Nitric oxide regulates the polyol pathway of glucose metabolism in vascular smooth muscle cells. The FASEB Journal 2003 17 3 417 425 2-s2.0-0037336421 10.1096/fj.02-0722com (Pubitemid 36292957)
45. Shield J. P., Poyser K., Hunt L., Pennock C. A., Fructosamine and glycated haemoglobin in the assessment of long term glycaemic control in diabetes. Archives of Disease in Childhood 1994 71 5 443 445 2-s2.0-0028039082 (Pubitemid 24349856)
46. Diabetes UK. HbA1c (Glycated haemoglobin) and fructosamine. 2011, http://www.diabetes.org.uk/hba1c
47. Robertson A. P., Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. The Journal of Biological Chemistry 2004 279 41 42351 42354 2-s2.0-5644248079 10.1074/jbc.R400019200 (Pubitemid 39372114)